Zimmer Biomet Holdings (ZBH)
Zimmer Biomet Holdings on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on NYSE, classified by the SEC as orthopedic, prosthetic & surgical appliances & supplies.
9.7M
Short interest
settlement 2026-09-30
4.4
Days to cover
unchanged vs prior
52.5%
Short share of volume
2026-10-09
4,456
Fails to deliver
settlement 2026-08-31
Wed 4 Nov
Next earnings
estimated date
-$824K
Insider flow, 90 days
0 buys, 2 sells
As of 2026-10-09.
Short interest
FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in ZBH is 9,745,945 shares, up 957,711 shares over the last month. Over the last 48 readings it ranged from 5,510,352 shares (30 May 2025) to 12,054,804 shares (15 July 2026). At the reported average volume of 2.2M shares a day that is 4.4 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/zbh" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 9,745,945 | +13.6% | 2,220,737 | 4.39 |
| 2026-09-15 | 8,576,677 | -2.4% | 1,947,674 | 4.40 |
| 2026-08-31 | 8,788,234 | -0.1% | 1,356,805 | 6.48 |
| 2026-08-14 | 8,795,152 | -21.3% | 2,997,079 | 2.93 |
| 2026-07-31 | 11,180,764 | -7.3% | 2,295,615 | 4.87 |
| 2026-07-15 | 12,054,804 | +2.0% | 2,330,342 | 5.17 |
| 2026-06-30 | 11,817,407 | +1.1% | 2,551,854 | 4.63 |
| 2026-06-15 | 11,684,703 | +34.0% | 2,006,104 | 5.82 |
| 2026-05-29 | 8,717,891 | -4.9% | 2,307,255 | 3.78 |
| 2026-05-15 | 9,163,593 | -8.3% | 2,238,639 | 4.09 |
| 2026-04-30 | 9,996,758 | -0.9% | 3,108,804 | 3.22 |
| 2026-04-15 | 10,086,123 | +0.8% | 1,989,977 | 5.07 |
| 2026-03-31 | 10,000,836 | +24.8% | 1,963,892 | 5.09 |
| 2026-03-13 | 8,016,066 | +4.2% | 2,193,953 | 3.65 |
| 2026-02-27 | 7,690,863 | -8.6% | 2,017,576 | 3.81 |
| 2026-02-13 | 8,412,337 | -14.1% | 2,748,111 | 3.06 |
| 2026-01-30 | 9,793,959 | +3.5% | 2,073,077 | 4.72 |
| 2026-01-15 | 9,460,201 | -8.5% | 2,441,246 | 3.88 |
| 2025-12-31 | 10,334,707 | +33.0% | 1,680,832 | 6.15 |
| 2025-12-15 | 7,772,345 | -8.5% | 2,348,062 | 3.31 |
| 2025-11-28 | 8,496,861 | +12.6% | 1,991,960 | 4.27 |
| 2025-11-14 | 7,547,747 | +3.8% | 3,261,017 | 2.31 |
| 2025-10-31 | 7,273,875 | +1.9% | 1,297,194 | 5.61 |
| 2025-10-15 | 7,137,828 | +5.0% | 1,192,930 | 5.98 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 9 October 2026, the short share of ZBH volume is 52.5%, up 9.8 points over the last five sessions. Over the last 30 readings it ranged from 27.6% (17 September 2026) to 72.0% (15 September 2026). The latest reading is 2.6 points above the 30-session average of 49.9%, on 552K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-09 | 290K | 552K | 52.5% | 101 |
| 2026-10-08 | 330K | 743K | 44.4% | 335 |
| 2026-10-07 | 380K | 622K | 61.1% | 192 |
| 2026-10-06 | 281K | 611K | 46.0% | 573 |
| 2026-10-05 | 287K | 997K | 28.8% | 247 |
| 2026-10-02 | 276K | 646K | 42.7% | 1,334 |
| 2026-10-01 | 210K | 743K | 28.3% | 732 |
| 2026-09-30 | 323K | 865K | 37.4% | 119 |
| 2026-09-29 | 257K | 598K | 42.9% | 767 |
| 2026-09-28 | 328K | 549K | 59.9% | 1,504 |
| 2026-09-25 | 293K | 681K | 43.1% | 1,055 |
| 2026-09-24 | 669K | 1.2M | 54.7% | 4,127 |
| 2026-09-23 | 585K | 1.3M | 46.1% | 280 |
| 2026-09-22 | 223K | 578K | 38.6% | 68 |
| 2026-09-21 | 220K | 533K | 41.3% | 0 |
| 2026-09-18 | 290K | 788K | 36.8% | 208 |
| 2026-09-17 | 253K | 915K | 27.6% | 0 |
| 2026-09-16 | 289K | 705K | 41.0% | 126 |
| 2026-09-15 | 1.3M | 1.8M | 72.0% | 132 |
| 2026-09-14 | 462K | 827K | 55.9% | 10,308 |
| 2026-09-11 | 429K | 838K | 51.2% | 110 |
| 2026-09-10 | 280K | 591K | 47.4% | 610 |
| 2026-09-09 | 494K | 687K | 71.8% | 861 |
| 2026-09-08 | 795K | 1.3M | 61.1% | 336 |
| 2026-09-04 | 305K | 487K | 62.6% | 0 |
| 2026-09-03 | 264K | 441K | 59.7% | 1,552 |
| 2026-09-02 | 316K | 476K | 66.3% | 0 |
| 2026-09-01 | 334K | 583K | 57.3% | 644 |
| 2026-08-31 | 225K | 373K | 60.3% | 0 |
| 2026-08-28 | 189K | 327K | 57.6% | 231 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 31 August 2026, the fails-to-deliver balance in ZBH is 4,456 shares, down 11,904 shares over the last settlement date. Over the last 30 readings it ranged from 3 shares (4 June 2026) to 46,375 shares (3 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-31 | 4,456 | $100.91 | $450K |
| 2026-08-24 | 16,360 | $100.98 | $1.7M |
| 2026-08-20 | 5,448 | $100.74 | $549K |
| 2026-07-29 | 1,270 | $95.75 | $122K |
| 2026-07-28 | 24,855 | $92.07 | $2.3M |
| 2026-07-22 | 2,052 | $88.92 | $182K |
| 2026-07-21 | 29,943 | $89.72 | $2.7M |
| 2026-07-17 | 3 | $93.75 | $281 |
| 2026-07-13 | 80 | $91.34 | $7K |
| 2026-07-01 | 9,305 | $86.09 | $801K |
| 2026-06-30 | 13,900 | $91.24 | $1.3M |
| 2026-06-29 | 57 | $93.10 | $5K |
| 2026-06-23 | 17,579 | $87.09 | $1.5M |
| 2026-06-22 | 24 | $87.97 | $2K |
| 2026-06-18 | 3 | $87.16 | $261 |
| 2026-06-16 | 2,154 | $88.26 | $190K |
| 2026-06-15 | 15,978 | $88.57 | $1.4M |
| 2026-06-12 | 6 | $87.14 | $523 |
| 2026-06-09 | 62 | $87.27 | $5K |
| 2026-06-08 | 312 | $87.33 | $27K |
| 2026-06-04 | 3 | $84.98 | $255 |
| 2026-06-03 | 46,375 | $83.75 | $3.9M |
| 2026-05-26 | 1,290 | $85.50 | $110K |
| 2026-05-20 | 698 | $86.08 | $60K |
| 2026-05-19 | 14 | $85.14 | $1K |
| 2026-05-08 | 107 | $83.37 | $9K |
| 2026-05-01 | 87 | $82.43 | $7K |
| 2026-04-28 | 10 | $92.59 | $926 |
| 2026-04-27 | 302 | $91.26 | $28K |
| 2026-04-23 | 14,583 | $93.04 | $1.4M |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at ZBH reported 2 open-market sells worth $824K in the last 90 days and no open-market buys. Latest filing: Campbell Gary Craig (President, Americas) on 2026-10-01.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Campbell Gary Craig | President, Americas | Tax withholding | 480 | $88.42 | $42K | 2K |
| 2026-10-01 | Campbell Gary Craig | President, Americas | Option exercise | 1K | $0.00 | $0 | 3K |
| 2026-10-01 | Campbell Gary Craig | President, Americas | Tax withholding | 932 | $88.42 | $82K | 1K |
| 2026-10-01 | Campbell Gary Craig | President, Americas | Option exercise | 2K | $0.00 | $0 | 2K |
| 2026-09-11 | Thornal Kevin R | Grp Pres-Global Business | Sell | 6K | $92.95 | $529K | 0 |
| 2026-09-04 | Phipps Chad F | See remarks below. | Sell | 3K | $98.35 | $295K | 65K |
| 2026-08-01 | Thornal Kevin R | Grp Pres-Global Business | Tax withholding | 4K | $92.68 | $395K | 6K |
| 2026-08-01 | Thornal Kevin R | Grp Pres-Global Business | Option exercise | 10K | $0.00 | $0 | 10K |
| 2026-05-29 | Yi Sang | Group President, Asia Pacific | Sell | 800 | $82.66 | $66K | 27K |
| 2026-05-29 | Yi Sang | Group President, Asia Pacific | Sell | 4K | $82.64 | $347K | 28K |
| 2026-04-01 | Noor Jehanzeb | See remarks below. | Tax withholding | 2K | $90.67 | $152K | 5K |
| 2026-04-01 | Noor Jehanzeb | See remarks below. | Option exercise | 7K | $0.00 | $0 | 7K |
| 2026-03-12 | Winkler Lori | SVP and CHRO | Sell | 3K | $94.66 | $251K | 10K |
| 2026-03-06 | Yi Sang | Group President, Asia Pacific | Option exercise | 2K | $0.00 | $0 | 32K |
| 2026-03-06 | Yi Sang | Group President, Asia Pacific | Option exercise | 7K | $0.00 | $0 | 30K |
| 2026-03-06 | Winkler Lori | SVP and CHRO | Tax withholding | 629 | $92.54 | $58K | 13K |
| 2026-03-06 | Winkler Lori | SVP and CHRO | Option exercise | 2K | $0.00 | $0 | 14K |
| 2026-03-06 | Winkler Lori | SVP and CHRO | Tax withholding | 2K | $92.54 | $143K | 12K |
| 2026-03-06 | Winkler Lori | SVP and CHRO | Option exercise | 4K | $0.00 | $0 | 13K |
| 2026-03-06 | VAN ZUILEN WILFRED | Group Pres, EMEA | Tax withholding | 562 | $92.54 | $52K | 31K |
| 2026-03-06 | VAN ZUILEN WILFRED | Group Pres, EMEA | Option exercise | 2K | $0.00 | $0 | 32K |
| 2026-03-06 | VAN ZUILEN WILFRED | Group Pres, EMEA | Tax withholding | 1K | $92.54 | $117K | 29K |
| 2026-03-06 | VAN ZUILEN WILFRED | Group Pres, EMEA | Option exercise | 5K | $0.00 | $0 | 31K |
| 2026-03-06 | Upadhyay Suketu | Exec VP, CFO | Tax withholding | 2K | $92.54 | $188K | 69K |
| 2026-03-06 | Upadhyay Suketu | Exec VP, CFO | Option exercise | 5K | $0.00 | $0 | 72K |
| 2026-03-06 | Upadhyay Suketu | Exec VP, CFO | Tax withholding | 5K | $92.54 | $421K | 67K |
| 2026-03-06 | Upadhyay Suketu | Exec VP, CFO | Option exercise | 10K | $0.00 | $0 | 72K |
| 2026-03-06 | Tornos Ivan | Chairman, President and CEO | Tax withholding | 3K | $92.54 | $278K | 83K |
| 2026-03-06 | Tornos Ivan | Chairman, President and CEO | Option exercise | 5K | $0.00 | $0 | 86K |
| 2026-03-06 | Tornos Ivan | Chairman, President and CEO | Tax withholding | 3K | $92.54 | $247K | 81K |
| 2026-03-06 | Tornos Ivan | Chairman, President and CEO | Option exercise | 5K | $0.00 | $0 | 83K |
| 2026-03-06 | Tornos Ivan | Chairman, President and CEO | Tax withholding | 14K | $92.54 | $1.3M | 79K |
| 2026-03-06 | Tornos Ivan | Chairman, President and CEO | Option exercise | 24K | $0.00 | $0 | 92K |
| 2026-03-06 | Stellato Paul A | VP, Controller, CAO | Tax withholding | 282 | $92.54 | $26K | 6K |
| 2026-03-06 | Stellato Paul A | VP, Controller, CAO | Option exercise | 607 | $0.00 | $0 | 6K |
| 2026-03-06 | Stellato Paul A | VP, Controller, CAO | Tax withholding | 633 | $92.54 | $59K | 5K |
| 2026-03-06 | Stellato Paul A | VP, Controller, CAO | Option exercise | 1K | $0.00 | $0 | 6K |
| 2026-03-06 | Phipps Chad F | See remarks below. | Tax withholding | 843 | $92.54 | $78K | 68K |
| 2026-03-06 | Phipps Chad F | See remarks below. | Option exercise | 2K | $0.00 | $0 | 69K |
| 2026-03-06 | Phipps Chad F | See remarks below. | Tax withholding | 2K | $92.54 | $175K | 67K |
| 2026-03-06 | Phipps Chad F | See remarks below. | Option exercise | 5K | $0.00 | $0 | 68K |
| 2026-02-25 | Yi Sang | Group President, Asia Pacific | Option exercise | 3K | $0.00 | $0 | 23K |
| 2026-02-25 | Winkler Lori | SVP and CHRO | Tax withholding | 924 | $99.51 | $92K | 9K |
| 2026-02-25 | Winkler Lori | SVP and CHRO | Option exercise | 2K | $0.00 | $0 | 10K |
| 2026-02-25 | VAN ZUILEN WILFRED | Group Pres, EMEA | Tax withholding | 828 | $99.51 | $82K | 26K |
| 2026-02-25 | VAN ZUILEN WILFRED | Group Pres, EMEA | Option exercise | 3K | $0.00 | $0 | 27K |
| 2026-02-25 | Upadhyay Suketu | Exec VP, CFO | Tax withholding | 3K | $99.51 | $282K | 61K |
| 2026-02-25 | Upadhyay Suketu | Exec VP, CFO | Option exercise | 6K | $0.00 | $0 | 64K |
| 2026-02-25 | Tornos Ivan | Chairman, President and CEO | Tax withholding | 11K | $99.51 | $1.1M | 68K |
| 2026-02-25 | Tornos Ivan | Chairman, President and CEO | Option exercise | 19K | $0.00 | $0 | 78K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON9 Form 144 notices on file for ZBH worth $5.8M at the prices reported; 3 in the last 90 days worth $1.5M. Latest: Thornal Kevin R filed on 2026-09-11 to sell 5,691 shares ($529K) from 2026-09-11.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-11 | Thornal Kevin ROfficer | 6K | $529K | 0.003% | 2026-09-11 | Fidelity Brokerage Services LLC |
| 2026-09-04 | Phipps Chad FOfficer | 3K | $295K | 0.002% | 2026-09-04 | Fidelity Brokerage Services LLC |
| 2026-07-16 | Upadhyay SuketuFormer Officer | 8K | $712K | 0.004% | 2026-07-16 | Fidelity Brokerage Services LLC |
| 2026-06-24 | Upadhyay SuketuFormer Officer | 5K | $411K | 0.002% | 2026-06-24 | Fidelity Brokerage Services LLC |
| 2026-05-29 | Yi SangOfficer | 5K | $413K | 0.003% | 2026-05-29 | Fidelity Brokerage Services LLC |
| 2026-05-19 | Upadhyay SuketuFormer Officer | 5K | $464K | 0.003% | 2026-05-19 | Fidelity Brokerage Services LLC |
| 2026-05-12 | Upadhyay SuketuFormer Officer | 31K | $2.6M | 0.016% | 2026-05-12 | Fidelity Brokerage Services LLC |
| 2026-03-12 | Winkler LoriOfficer | 3K | $251K | 0.001% | 2026-03-12 | Fidelity Brokerage Services LLC |
| 2026-02-12 | Yi SangOfficer | 1K | $96K | 0.001% | 2026-02-12 | Fidelity Brokerage Services LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON5 holders report 5% or more of ZBH in their latest filing, all on Schedule 13G (passive). The largest reported stake is Dodge & Cox at 12.5% of the class (24,124,735 shares), filed 2026-08-13 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-13 | 13G/Ano. 5 | Dodge & Coxinvestment adviser | 24.1M | 12.5% | 2026-06-30 |
| 2026-08-12 | 13G | Capital International Investorsinvestment adviser | 12.4M | 6.4% | 2026-06-30 |
| 2026-05-15 | 13G/Ano. 1 | T. Rowe Price Associates, Inc.investment adviser | 8.0M | 4.1% | 2026-03-31 |
| 2026-04-30 | 13G | Vanguard Capital Managementinvestment adviser | 14.8M | 7.5% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 9 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-02-17 | 13G | HARRIS ASSOCIATES L Pinvestment adviser | 12.3M | 6.2% | 2025-12-31 |
| 2026-02-17 | 13G | Harris Associates, Inc.corporation | 12.3M | 6.2% | 2025-12-31 |
13F holders
Tracked managers holding ZBH at their latest 13F. JSON7 of the 30 tracked managers held ZBH at their latest 13F, $435.0M in total at quarter-end prices. Citadel Advisors is the largest at $299.4M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 7 added shares and 0 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 3.5M | $299.4M | 0.03% | +2.1M |
| Point72 Asset Management | 2026-06-30 | 880K | $75.7M | 0.08% | new |
| AQR Capital Management | 2026-06-30 | 367K | $31.3M | 0.01% | +40K |
| Millennium Management | 2026-06-30 | 222K | $19.1M | 0.01% | new |
| Two Sigma Investments | 2026-06-30 | 50K | $4.3M | 0.00% | +18K |
| Bridgewater Associates | 2026-06-30 | 36K | $3.1M | 0.01% | +2K |
| D. E. Shaw & Co. | 2026-06-30 | 24K | $2.1M | 0.00% | +15K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Zimmer Biomet Holdings reported revenue of $2.18B, up 4.8% from the same quarter a year earlier, and net income of $198.3M (1.03 diluted EPS). In FY 2025 it generated $1.70B of operating cash flow and spent $487.0M on buybacks and $190.3M on dividends. As of 2026-06-30, cash was $410.0M against $6.28B of debt.
- Cash
- $410.0M
- Debt
- $6.28B
- Equity
- $12.62B
- Total assets
- $22.80B
- Shares outstanding
- 190,737,689
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $2.18B | $198.3M | 9.1% | 1.03 |
| Q1 FY 2026 | 2026-03-31 | $2.09B | $238.1M | 11.4% | 1.22 |
| Q4 FY 2025derived | 2025-12-31 | $2.24B | $139.4M | 6.2% | n/a |
| Q3 FY 2025 | 2025-09-30 | $2.00B | $230.9M | 11.5% | 1.16 |
| Q2 FY 2025 | 2025-06-30 | $2.08B | $152.8M | 7.4% | 0.77 |
| Q1 FY 2025 | 2025-03-31 | $1.91B | $182.0M | 9.5% | 0.91 |
| Q4 FY 2024derived | 2024-12-31 | $2.02B | $239.5M | 11.8% | n/a |
| Q3 FY 2024 | 2024-09-30 | $1.82B | $249.1M | 13.7% | 1.23 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $8.23B | $705.1M | $1.70B | $224.5M | $487.0M | $190.3M |
| FY 2024 | 2024-12-31 | $7.68B | $903.8M | $1.50B | $203.8M | $868.0M | $196.0M |
| FY 2023 | 2023-12-31 | $7.39B | $1.02B | $1.58B | $291.1M | $692.2M | $200.9M |
| FY 2022 | 2022-12-31 | $6.94B | $231.4M | n/a | $187.9M | $126.4M | $201.2M |
| FY 2021 | 2021-12-31 | $6.83B | $401.6M | $1.50B | $143.6M | n/a | $200.1M |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-30 from the cover page.
What this page is
Zimmer Biomet Holdings in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Zimmer Biomet Holdings (ZBH), SEC CIK 1136869, listed on NYSE, classified by the SEC as orthopedic, prosthetic & surgical appliances & supplies. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-08-31.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-11.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-13.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-05.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-01.JSON and CSV
- Company record
- EDGAR filing index for CIK 1136869Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as orthopedic, prosthetic & surgical appliances & supplies
Other company pages
Datasets
Frequently Asked Questions
How much of ZBH is sold short?
What is ZBH's daily short volume?
Does ZBH have fails to deliver?
Are ZBH insiders buying or selling?
Have ZBH insiders filed to sell?
Who owns 5% or more of ZBH?
What did ZBH report last quarter?
Which tracked 13F managers own ZBH?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.